Scandic Hotel Ambassadeur Drammen, January 25-26, 2024
Organized by: Vestre Viken Hospital Trust, the Cancer Registry of Norway and National Network for Breast Cancer Research
Welcome to “Drammensmøtet 2024” – a multidisciplinary breast cancer symposium targeting breast surgeons, radiologists and pathologists. The symposium this year will focus on B3 lesions, artificial intelligence in radiology and pathology, and neoadjuvant treatment.
Venue:
Hotel Scandic Ambassadeur in Drammen, next to Drammen Station. The hotel is reached within one hour by the Airport Express Train directly from Oslo Airport Gardermoen.
Fee:
2 days symposium incl. dinner Thursday and hotel accommodation Thurs-Fri: 3500 NOK
One day symposium excl. dinner/accommodation per day: 1000 NOK
Dinner Thursday (for participants not staying at the hotel): 600 NOK
Extra hotel accommodation (for participants arriving Wednesday, January 24) 1340 NOK
Registration by 19th of November: https://nettskjema.no/a/drammensmotet2024
Preliminary program (changes may occur):
Thursday January 25th
10.00 – 10.15 Welcome
Session I: B3 lesions
Chair: Anette Heie, Haukeland University Hospital
10.15 – 10.30 Status of B3 Lesions in Norway today (Anette Heie, Haukeland University Hospital)
10.30 – 11.15 B3 Lesions and radiology (Nisha Sharma, Leeds Teaching Hospital NHS Trust, UK)
11.15 – 11.30 15 minutes Coffee break
11.30 – 12.15 B3 Lesions and pathology (Ioannis Roxanis, Royal Free London NHS Foundation Trust & The Institute of Cancer Research – Breast Cancer Now Toby Robins Research Centre, UK)
12.15 – 12.45 Discussion
13.00 – 14.00 Lunch
Session II: Artificial intelligence in radiology and pathology
Chair: Solveig Hofvind, Cancer Registry of Norway
14.00 – 14.05 Introduction (Solveig Hofvind, Cancer Registry of Norway)
14.05 – 14.35 Studies on AI in BreastScreen Norway (Henrik Wethe Koch, Stavanger University Hospital and Marit A. Marthiniussen, Østfold Hospital)
14.35 – 15.05 AI in quality assessment of mammograms (Nisha Sharma, Leeds Teaching Hospital NHS Trust, UK)
15.05 – 15.20 15 minutes Coffee break
15.20 – 16.00 Experiences with AI in breast radiology and screening (Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany)
16.00 – 16.30 AI in pathology (Marit Valla, Norwegian University of Science and Technology)
16.30 – 17.00 Discussion
19.00 Dinner
Friday January 26th
Session III: Neoadjuvant treatment
Chair: Stine L’Orange, Oslo University Hospital
08.30 – 08.40 Status of Neoadjuvant treatment today (Stine L’Orange, Oslo University Hospital)
08.40 – 09.25 Neoadjuvant Therapy & Immunotherapy in breast cancer (Elena Provenzano, Cambridge University Hospitals NHS Foundation Trust, UK)
09.25 – 09.40 15 minutes Coffee break
09.40 – 10.20 Breast surgery after neoadjuvant treatment( Thorsten Kühn, Filderclinic, Germany)
10.20 – 11.00 Axillary surgery after neoadjuvant treatment (Jana de Boniface, Karolinska Institutet, Stockholm, Sweden)
11.00 – 11.30 Discussion
11.30 – 12.30 Lunch
Session IV: Case and project presentations
Chair: Kristine K Sahlberg, Vestre Viken Hospital
12.30 – 13.00 Interval breast cancer in screening – duty of disclosure, incl discussion (Einar Vigeland, Vestfold Hospital)
13.00 – 14.00 Multidiciplinary case presentations (Helle Skjerven, Thomas Papathomas, Tone Hovda, oncologist TBA, Vestre Viken Hospital)
14.00 – 14.15 15 minutes Coffee break
14.15 – 15.45 Project presentations (6 presentations, 15 min each including discussion)
15.45 – 16.00 Closing remarks
